Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$247M |
| 2 |
Johnson & Johnson
JNJ
|
+$225M |
| 3 |
MON
Monsanto Co
MON
|
+$213M |
| 4 |
AET
Aetna Inc
AET
|
+$208M |
| 5 |
Broadcom
AVGO
|
+$176M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$227M |
| 2 |
Microsoft
MSFT
|
+$224M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$205M |
| 4 |
Nike
NKE
|
+$187M |
| 5 |
Pfizer
PFE
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.12% |
| 2 | Technology | 12.96% |
| 3 | Healthcare | 12.08% |
| 4 | Industrials | 11.23% |
| 5 | Consumer Staples | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Royal Bank of Canada
RY
$292B
| $95.8M | 0.15% |
1,415,583
-13,900
| -1% | -$901K |
|
127
JetBlue
JBLU
$2.19B
| $95.3M | 0.15% |
4,250,300
-2,482,800
| -37% | -$49M |
|
128
Hershey
HSY
$36.6B
| $94.3M | 0.15% |
912,100
-204,300
| -18% | -$20.2M |
|
129
Mid-America Apartment Communities
MAA
$15.3B
| $94.2M | 0.15% |
962,341
+343,741
| +56% | +$31.6M |
|
130
HDFC Bank
HDB
$120B
| $94M | 0.15% |
+6,194,800
| New | +$104M |
|
131
Newmont
NEM
$124B
| $93.9M | 0.15% |
2,757,500
+1,458,200
| +112% | +$49.8M |
|
|
VAL
132
DELISTED
Valspar
VAL
| $93.2M | 0.15% |
900,000
+444,500
| +98% | +$45.8M |
|
|
LOGM
133
DELISTED
LogMein, Inc.
LOGM
| $92.5M | 0.15% |
957,800
-7,800
| -0.8% | -$758K |
|
|
134
Pfizer
PFE
$152B
| $92.5M | 0.15% |
3,000,738
-6,028,080
| -67% | -$184M |
|
|
COL
135
DELISTED
Rockwell Collins
COL
| $92.5M | 0.15% |
996,700
+682,500
| +217% | +$60.2M |
|
136
Regeneron Pharmaceuticals
REGN
$82.1B
| $92M | 0.15% |
+250,560
| New | +$95.3M |
|
137
Gaming and Leisure Properties
GLPI
$12.4B
| $91.8M | 0.15% |
2,997,489
+344,200
| +13% | +$10.8M |
|
138
Equity Lifestyle Properties
ELS
$12.4B
| $91.6M | 0.14% |
2,539,600
+456,000
| +22% | +$16.3M |
|
|
SAFM
139
DELISTED
Sanderson Farms Inc
SAFM
| $91M | 0.14% |
966,017
+342,900
| +55% | +$30.3M |
|
140
Ameren
AEE
$29.8B
| $90.6M | 0.14% |
1,727,600
+453,400
| +36% | +$22.5M |
|
141
Toronto Dominion Bank
TD
$201B
| $90.2M | 0.14% |
1,827,600
+75,300
| +4% | +$3.52M |
|
|
JCP
142
DELISTED
J.C. Penney Company, Inc.
JCP
| $90M | 0.14% |
10,825,000
-2,714,100
| -20% | -$24.5M |
|
143
American Tower
AMT
$79B
| $89.3M | 0.14% |
845,039
+141,139
| +20% | +$15.3M |
|
144
Applied Materials
AMAT
$417B
| $88.8M | 0.14% |
2,752,248
-1,644,300
| -37% | -$50M |
|
145
Emerson Electric
EMR
$91.7B
| $88.7M | 0.14% |
+1,591,900
| New | +$85.6M |
|
146
Fidelity National Information Services
FIS
$22.1B
| $88.3M | 0.14% |
1,167,401
+962,300
| +469% | +$73.4M |
|
|
AZPN
147
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $88M | 0.14% |
1,608,500
+74,000
| +5% | +$4.05M |
|
148
Sherwin-Williams
SHW
$88.5B
| $87.6M | 0.14% |
978,000
+378,900
| +63% | +$33.5M |
|
149
Chunghwa Telecom
CHT
$32.9B
| $87.4M | 0.14% |
2,769,184
+410,300
| +17% | +$13.8M |
|
150
Halliburton
HAL
$28.2B
| $87.1M | 0.14% |
+1,610,895
| New | +$80.3M |
|
Similar funds
Jim Simons's Q4 2016 Portfolio in Review
As of Q4 2016, Jim Simons held 3,715 positions worth $63.2B, up 12% from $56.6B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
Jim Simons deployed $5.07B of net new capital in Q4 2016, opening 418 new positions and adding to 1,792 existing holdings. Its largest new stake was Broadcom: 10,144,960 shares worth $179M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $227M trimmed.
- Jim Simons's largest Q4 2016 buy was Broadcom: 10,144,960 shares worth $179M.
- Jim Simons added most to Gilead Sciences in Q4 2016, an estimated $247M increase.
- Jim Simons's biggest Q4 2016 reduction was Bristol-Myers Squibb, cutting an estimated $227M.
- Jim Simons fully exited Alphabet (Google) Class C in Q4 2016, selling an estimated $205M.
- Jim Simons's ten largest holdings make up 7.2% of its $63.2B portfolio in Q4 2016.
- Jim Simons opened 418 new positions and closed 494 in Q4 2016.
- Jim Simons's portfolio value rose 12% quarter-over-quarter to $63.2B.
Based on Renaissance Technologies's 13F filing for Q4 2016, filed 13 Feb 2017.